Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?

被引：0
|
作者：
Andrew Jacobs
机构：
[1] Chief of Cancer Care Services and Medical Director of Clinical Research at the Benaroya Research Institute at Virginia Mason Medical Center,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：424 / 425
页数：1
相关论文
共 50 条
  • [21] SEQUENTIAL CHEMOTHERAPY WITH GEMCITABINE plus CARBOPLATIN FOLLOWED BY GEMCITABINE plus CARBOPLATIN plus DOCETAXEL FOR ADVANCED UPPER-TRACT UROTHELIAL CANCER
    Yoneyama, T.
    Tokui, N.
    Imanishi, K.
    Sugiyama, N.
    Hatakeyama, S.
    Kudo, S.
    Yoneyama, T.
    Mori, K.
    Koie, T.
    Kamimura, N.
    Ohyama, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 211 - 211
  • [22] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [23] Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity
    Solomon, B
    Bunn, PA
    CANCER TREATMENT REVIEWS, 2005, 31 (07) : 571 - 576
  • [24] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
    Georgoulias, V
    Ardavanis, A
    Tsiafaki, X
    Agelidou, A
    Mixalopoulou, P
    Anagnostopoulou, O
    Ziotopoulos, P
    Toubis, M
    Syrigos, K
    Samaras, N
    Polyzos, A
    Christou, A
    Kakolyris, S
    Kouroussis, C
    Androulakis, N
    Samonis, G
    Chatzidaki, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2937 - 2945
  • [25] Sequential chemotherapy using gemcitabine plus carboplatin followed by gemcitabine plus carboplatin plus docetaxel for advanced upper-tract urothelial cancer
    Yoneyama, Takahiro
    Imai, Atsushi
    Hatakeyama, Shingo
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1179 - 1184
  • [26] Ramucirumab plus docetaxel for urothelial carcinoma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (04): : E140 - E140
  • [27] Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Yang, Jiangping
    Han, Jiaqi
    He, Jinlan
    Duan, Baofeng
    Gou, Qiheng
    Ai, Ping
    Liu, Lei
    Li, Yanchu
    Ren, Kexing
    Wang, Feng
    Yao, Min
    Chen, Nianyong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [28] Modified Docetaxel plus Cisplatin plus Capecitabine (DCX) for Gastric Cancer
    Maeda, Osamu
    Ando, Yuichi
    Matsuoka, Ayumu
    Furukawa, Kazuhiro
    Funasaka, Kohei
    Miyahara, Ryoji
    Hirooka, Yoshiki
    Goto, Hidemi
    DIGESTION, 2019, 99 (01) : 113 - 113
  • [29] Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
    Kitadani, Junya
    Ojima, Toshiyasu
    Hayata, Keiji
    Goda, Taro
    Takeuchi, Akihiro
    Tominaga, Shinta
    Fukuda, Naoki
    Nakai, Tomoki
    Yamaue, Hiroki
    Kawai, Manabu
    ONCOLOGY, 2024, 102 (03) : 228 - 238
  • [30] Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma
    van der Heijden, M. S.
    Sonpavde, G.
    Powles, T.
    Necchi, A.
    Burotto, M.
    Schenker, M.
    Sade, J. P.
    Bamias, A.
    Beuzeboc, P.
    Bedke, J.
    Oldenburg, J.
    Chatta, G.
    Urun, Y.
    Ye, D.
    He, Z.
    Valderrama, B. P.
    Ku, J. H.
    Tomita, Y.
    Filian, J.
    Wang, L.
    Purcea, D.
    Patel, M. Y.
    Nasroulah, F.
    Galsky, M. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (19): : 1778 - 1789
12345